Literature DB >> 10651314

Induction of c-met proto-oncogene expression at the metastatic site.

J Imai1, M Watanabe, M Sasaki, R Yamaguchi, S Tateyama, S Sugano.   

Abstract

In metastatic processes, gene expression may variously alter through interactions between tumor and host stromal cells at the metastatic site. Using a tail vein injection-lung metastatic model and differential display, we analyzed alteration of gene expression in experimentally metastasized lesions. We found that expression of the c-met proto-oncogene was elevated in the lungs metastasized by MC-1 cells. The up-regulation of c-met was also observed in the lungs metastasized by B16 melanoma cells. In situ hybridization analysis revealed that the elevation of c-met expression apparently occurred in tumor cells but did not in lung stromal cells at the metastatic site. The c-Met protein was also highly expressed and phosphorylated. The upregulation of c-met appeared to be caused by induction of gene expression but not to be due to preferential selection of tumor cells highly expressing c-met. These findings suggest that the c-met proto-oncogene is up-regulated at the transcription level through some interactions between tumor and host stromal cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10651314     DOI: 10.1023/a:1006659515706

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  45 in total

1.  Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.

Authors:  R Ferracini; M Olivero; M F Di Renzo; M Martano; C De Giovanni; P Nanni; G Basso; K Scotlandi; P L Lollini; P M Comoglio
Journal:  Oncogene       Date:  1996-04-18       Impact factor: 9.867

2.  Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines.

Authors:  P B Armstrong; J P Quigley; E Sidebottom
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

3.  Molecular cloning of a new transforming gene from a chemically transformed human cell line.

Authors:  C S Cooper; M Park; D G Blair; M A Tainsky; K Huebner; C M Croce; G F Vande Woude
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

4.  Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display.

Authors:  Y Hashimoto; N Shindo-Okada; M Tani; K Takeuchi; H Toma; J Yokota
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

5.  Frequent amplification of the c-met gene in scirrhous type stomach cancer.

Authors:  H Kuniyasu; W Yasui; Y Kitadai; H Yokozaki; H Ito; E Tahara
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

6.  Met expression and sarcoma tumorigenicity.

Authors:  S Rong; M Jeffers; J H Resau; I Tsarfaty; M Oskarsson; G F Vande Woude
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

Review 7.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

8.  Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.

Authors:  S Rong; L A Donehower; M F Hansen; L Strong; M Tainsky; M Jeffers; J H Resau; E Hudson; I Tsarfaty; G F Vande Woude
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

9.  Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases.

Authors:  O Picard; Y Rolland; M F Poupon
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

10.  Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer.

Authors:  J Yamashita; M Ogawa; S Yamashita; K Nomura; M Kuramoto; T Saishoji; S Shin
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  1 in total

1.  Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis.

Authors:  K Fazekas; O Csuka; I Köves; E Rásó; J Tímár
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.